$ELAN

$22.65 -$0.31 (1.35%) Close

$ELAN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ELAN Management Team

Mr. Lawrence Kurzius

Independent Chairman of the Board

Age 67

Compensation $426.1K USD

Sex Male

Mr. Jeffrey Simmons

President

Chief Executive Officer

Director

Age 57

Compensation $14.83M USD

Sex Male

Mr. Robert Vanhimbergen

Executive Vice President

Chief Financial Officer

Age 49

Compensation -

Sex Male

Mr. Todd Young

Chief Financial Officer

Executive Vice President

Age 53

Compensation $4.109M USD

Sex Male

Ms. Shiv O'Neill

Executive Vice President

General Counsel

Corporate Secretary

Age 51

Compensation -

Sex Female

Mr. David Kinard

Executive Vice President - Human Resources

Corporate Communications and Administration

Age 58

Compensation $2.851M USD

Sex Male

Mr. Timothy Bettington

Executive Vice President - Corporate Strategy and Market Development

Age 51

Compensation $2.533M USD

Sex Male

Dr. Ramiro Cabral

Executive Vice President; President of Elanco International

Age 53

Compensation $2.942M USD

Sex Male

Dr. Ellen de Brabander

Executive Vice President - Innovation and Regulatory Affairs

Age 62

Compensation $3.914M USD

Sex Female

Ms. Grace Mcardle

Executive Vice President - Manufacturing and Quality

Age 46

Compensation -

Sex Female

Mr. Rajeev Modi

Executive Vice President - U.S. Pet Health and Global Digital Transformation

Age 44

Compensation $2.222M USD

Sex Male

Dr. Jose Manuel Simas

Executive Vice President - U.S. Farm Animal Business

Age 57

Compensation -

Sex Male

Mr. James Meer

Senior Vice President

Chief Accounting Officer

Age 55

Compensation -

Sex Male

Ms. Tiffany Kanaga

IR Contact Officer

Age -

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Lawrence Kurzius Independent Chairman of the Board	67	$426.1K USD	Male
Mr. Jeffrey Simmons President Chief Executive Officer Director	57	$14.83M USD	Male
Mr. Robert Vanhimbergen Executive Vice President Chief Financial Officer	49	-	Male
Mr. Todd Young Chief Financial Officer Executive Vice President	53	$4.109M USD	Male
Ms. Shiv O'Neill Executive Vice President General Counsel Corporate Secretary	51	-	Female
Mr. David Kinard Executive Vice President - Human Resources Corporate Communications and Administration	58	$2.851M USD	Male
Mr. Timothy Bettington Executive Vice President - Corporate Strategy and Market Development	51	$2.533M USD	Male
Dr. Ramiro Cabral Executive Vice President; President of Elanco International	53	$2.942M USD	Male
Dr. Ellen de Brabander Executive Vice President - Innovation and Regulatory Affairs	62	$3.914M USD	Female
Ms. Grace Mcardle Executive Vice President - Manufacturing and Quality	46	-	Female
Mr. Rajeev Modi Executive Vice President - U.S. Pet Health and Global Digital Transformation	44	$2.222M USD	Male
Dr. Jose Manuel Simas Executive Vice President - U.S. Farm Animal Business	57	-	Male
Mr. James Meer Senior Vice President Chief Accounting Officer	55	-	Male
Ms. Tiffany Kanaga IR Contact Officer	-	-	Female

Board of Directors

From the proxy statement filed Apr 8, 2026

Directors

serving now

Independent

10 of 11

stated in the proxy

Average tenure

6.8 years

from year joined

CEO also chairs the board

Lawrence Kurzius

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Kapila Anand	72	2018 8 years	Independent	None stated	Omega Healthcare Investors Inc.	$297,507
Paul Herendeen	70	2020 6 years	Independent	None stated	Grifols, S.A.	$340,029
Michael Harrington	63	2018 8 years	Independent	None stated	Inotiv, Inc.	$346,007
Lawrence Kurzius Board chair	68	2018 8 years	Independent	None stated	The Cooper Companies, Inc., Lamb Weston Holdings, Inc.	$480,007
Kirk McDonald	59	2019 7 years	Independent	None stated	Ziff Davis, Inc.	$350,007
Art Garcia	65	2019 7 years	Independent	None stated	Raymond James & Associates, American Electric Power Company, Inc., ABM Industries Incorporated	$330,007
Stacey Ma	56	2024 2 years	Independent	Compensation and Human Capital	None stated	$252,480
Denise Scots-Knight	66	2019 7 years	Independent	None stated	Mereo BioPharma Group plc	$330,007
Jeffrey Simmons CEO	58	2018 8 years	Not independent	None stated	None stated	Paid as CEO
R. David Hoover Leaving at the meeting	Not stated	Not stated	Independent	None stated	None stated	$330,007
Deborah Kochevar Leaving at the meeting	Not stated	Not stated	Independent	None stated	None stated	$346,007

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 8, 2026

WEDterinary LLC

William Doyle, a former director who resigned from the Board in March 2025, owns 33% of the equity interests of WED

Up to $4 million

2025

Research Agreement under which WED conducts research studies on targeted gene therapy and Elanco US pays up to $4 million to fund the research in exchange for certain intellectual property rights

With Elanco US Inc. Open in proxy

Comments

Company Executives

$ELAN Management Team

Mr. Lawrence Kurzius

Mr. Jeffrey Simmons

Mr. Robert Vanhimbergen

Mr. Todd Young

Ms. Shiv O'Neill

Mr. David Kinard

Mr. Timothy Bettington

Dr. Ramiro Cabral

Dr. Ellen de Brabander

Ms. Grace Mcardle

Mr. Rajeev Modi

Dr. Jose Manuel Simas

Mr. James Meer

Ms. Tiffany Kanaga

Board of Directors

Related-party transactions